MiR-124 acts as a tumor suppressor by inhibiting the translation of the cell cycle regulator cyclin dependent kinase 6 (CDK6) and by reducing the phosphorylation of the retinoblastoma protein (Rb) [19]. The gene discussed is CDK6; the disease is neoplasm.